If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.
Sadly we are at the mercy of everything that is bad about AIM. Too many basement traders looking to make £100 a day and bail on any rise and MM's who manipulate spreads to suit themselves. Add to that, promoters who over promise and under deliver and it's clear that AIM is a very risky market. Hoping that sentiment for miners will improve and I can get out of ORR with a decent return for the 4 years I 've been here but I won't be back.
Just wondering why would a fund drop 40m shares at this price. Do they have an inkling that nothing is happening here otherwise the fund manager will have Hell to pay if a sale comes along at multiples of 7p in the coming months.
The SP plummeted from the £12 high because they could not sell tests except to their partner and G&A costs were through the roof. Costs have since come down but sales are still minimal. In the last two years other competing products have emerged.
The ALGW year end could be completed in a fortnight due to minimal activity flowing through the books ( aside from the salaries of the outstanding leadership team)🤣. Waiting 4 months is likely to be a case of delaying the inevitable bad news for as long as possible. We’ll hear more jam tomorrow platitudes I’d suggest followed by options to themselves at 3p and a fund raise coming as a final boot in the proverbials for us mugs.
Looks like the party is over for the meme stock traders here. Fundamentals haven’t changed for months. Minimal sales despite FDA approval last year and cash running out monthly. It has a decent product but reluctance by the medical industry to adapt and alternatives coming to the market have stymied it. The general belief is that it will be taken private and a few well heeled investors will participate with the little PI’s cast aside.
Lots of newbies here hyping the SP - no company news on why yesterday went ape so it’s down to speculation . Good luck to those punting but bear in mind it went from £12 to 11p. Lots of approvals etc including FDA that spiked the price to £1.50 and then it drifted back. Revenues are minimal and costs are high in this company and cash is running out fast. Happy punting.